Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,647
Award facts
- Contract value 100% obligated
- $36,647.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $36,647.10 on a firm fixed-price basis, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The award, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support the Department of Defense's healthcare operations, with performance occurring at the company's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That parent contract, awarded November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning the contractor as a critical regional pharmaceutical supplier supporting military healthcare facilities worldwide. The PPV-G GEN V program represents part of a broader $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for Department of Defense operations globally, with DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrating its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMRJ?
SPE2DU26FEMRJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DU26FEMRJ worth?
The government has obligated $36,647 on SPE2DU26FEMRJ.
Is contract SPE2DU26FEMRJ an order under another contract?
Yes. SPE2DU26FEMRJ is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRJ competed?
The extent of competition for SPE2DU26FEMRJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award